National Bank of Canada’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35M Buy
506,146
+142,608
+39% +$9.85M 0.03% 329
2025
Q1
$25.2M Sell
363,538
-378,983
-51% -$26.3M 0.03% 386
2024
Q4
$63.9M Buy
742,521
+463,493
+166% +$39.9M 0.07% 214
2024
Q3
$33.2M Buy
279,028
+17,641
+7% +$2.1M 0.04% 324
2024
Q2
$37.9M Sell
261,387
-183,264
-41% -$26.6M 0.05% 231
2024
Q1
$57.1M Buy
444,651
+264,155
+146% +$33.9M 0.09% 168
2023
Q4
$18.5M Sell
180,496
-5,484
-3% -$561K 0.03% 357
2023
Q3
$16.9M Buy
185,980
+9,192
+5% +$834K 0.03% 370
2023
Q2
$14.3M Buy
176,788
+16,500
+10% +$1.33M 0.03% 388
2023
Q1
$12.8M Sell
160,288
-79,168
-33% -$6.3M 0.03% 321
2022
Q4
$16.2M Buy
239,456
+67,312
+39% +$4.55M 0.04% 283
2022
Q3
$8.62M Buy
172,144
+1,284
+0.8% +$64.3K 0.05% 351
2022
Q2
$9.51M Sell
170,860
-32,562
-16% -$1.81M 0.04% 327
2022
Q1
$11.6M Buy
203,422
+22,096
+12% +$1.26M 0.03% 326
2021
Q4
$10M Buy
+181,326
New +$10M 0.03% 322